Mohamed Genead
Algemeen Directeur bij Aviceda Therapeutics, Inc.
Actieve functies van Mohamed Genead
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Aviceda Therapeutics, Inc.
 Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - | |
| Oprichter | - | - | |
| President | - | - | |
| Bedrijfssecretaris | - | - | |
| Treasurer | - | - | |
Aviceda Ophthalmics, Inc.
 Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Algemeen Directeur | - | - |
| Voorzitter | - | - | |
| Financieel Directeur/CFO | - | - | |
| President | - | - | |
| Bedrijfssecretaris | - | - |
Loopbaan van Mohamed Genead
Eerdere bekende functies van Mohamed Genead
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Hoofd Techniek/Wetenschap/O&O | 01-05-2017 | 01-11-2017 |
| University of Illinois | Corporate Officer/Principal | - | - |
| OCUGEN, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Frankrijk | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Executive Officer | 2 |
| President | 2 |
Sectoraal
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |
- Beurs
- Insiders
- Mohamed Genead
- Ervaring
